Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
82.84
-0.34 (-0.41%)
At close: May 5, 2025, 4:00 PM
82.95
+0.11 (0.13%)
After-hours: May 5, 2025, 5:51 PM EDT

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of $208.01 billion. The enterprise value is $233.25 billion.

Market Cap 208.01B
Enterprise Value 233.25B

Important Dates

The last earnings date was Thursday, April 24, 2025, before market open.

Earnings Date Apr 24, 2025
Ex-Dividend Date Mar 17, 2025

Share Statistics

Merck & Co. has 2.51 billion shares outstanding. The number of shares has decreased by -0.30% in one year.

Current Share Class 2.51B
Shares Outstanding 2.51B
Shares Change (YoY) -0.30%
Shares Change (QoQ) -0.24%
Owned by Insiders (%) 0.05%
Owned by Institutions (%) 80.01%
Float 2.51B

Valuation Ratios

The trailing PE ratio is 12.04 and the forward PE ratio is 9.20. Merck & Co.'s PEG ratio is 0.74.

PE Ratio 12.04
Forward PE 9.20
PS Ratio 3.29
Forward PS 3.11
PB Ratio 4.33
P/TBV Ratio 19.06
P/FCF Ratio n/a
P/OCF Ratio 9.95
PEG Ratio 0.74
Financial Ratio History

Enterprise Valuation

EV / Earnings 13.38
EV / Sales 3.65
EV / EBITDA 8.10
EV / EBIT 9.56
EV / FCF n/a

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.72.

Current Ratio 1.41
Quick Ratio 0.83
Debt / Equity 0.72
Debt / EBITDA 1.20
Debt / FCF n/a
Interest Coverage 19.06

Financial Efficiency

Return on equity (ROE) is 39.29% and return on invested capital (ROIC) is 19.33%.

Return on Equity (ROE) 39.29%
Return on Assets (ROA) 13.81%
Return on Invested Capital (ROIC) 19.33%
Return on Capital Employed (ROCE) 27.14%
Revenue Per Employee $852,293
Profits Per Employee $232,453
Employee Count 75,000
Asset Turnover 0.58
Inventory Turnover 2.31

Taxes

In the past 12 months, Merck & Co. has paid $2.72 billion in taxes.

Income Tax 2.72B
Effective Tax Rate 13.48%

Stock Price Statistics

The stock price has decreased by -35.03% in the last 52 weeks. The beta is 0.44, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y) 0.44
52-Week Price Change -35.03%
50-Day Moving Average 87.08
200-Day Moving Average 101.17
Relative Strength Index (RSI) 48.53
Average Volume (20 Days) 17,073,577

Short Selling Information

The latest short interest is 41.93 million, so 1.67% of the outstanding shares have been sold short.

Short Interest 41.93M
Short Previous Month 37.13M
Short % of Shares Out 1.67%
Short % of Float 1.67%
Short Ratio (days to cover) 2.29

Income Statement

In the last 12 months, Merck & Co. had revenue of $63.92 billion and earned $17.43 billion in profits. Earnings per share was $6.88.

Revenue 63.92B
Gross Profit 49.27B
Operating Income 24.41B
Pretax Income n/a
Net Income 17.43B
EBITDA 28.80B
EBIT 24.41B
Earnings Per Share (EPS) $6.88
Full Income Statement

Balance Sheet

The company has $9.23 billion in cash and $34.84 billion in debt, giving a net cash position of -$25.62 billion or -$10.20 per share.

Cash & Cash Equivalents 9.23B
Total Debt 34.84B
Net Cash -25.62B
Net Cash Per Share -$10.20
Equity (Book Value) 48.40B
Book Value Per Share 19.21
Working Capital 10.33B
Full Balance Sheet

Cash Flow

Operating Cash Flow 20.88B
Capital Expenditures -3.84B
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 77.07%, with operating and profit margins of 38.19% and 27.27%.

Gross Margin 77.07%
Operating Margin 38.19%
Pretax Margin 31.55%
Profit Margin 27.27%
EBITDA Margin 45.05%
EBIT Margin 38.19%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of $3.24, which amounts to a dividend yield of 3.91%.

Dividend Per Share $3.24
Dividend Yield 3.91%
Dividend Growth (YoY) 5.33%
Years of Dividend Growth 10
Payout Ratio 47.10%
Buyback Yield 0.30%
Shareholder Yield 4.21%
Earnings Yield 8.40%
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for Merck & Co. is $115.93, which is 39.94% higher than the current price. The consensus rating is "Buy".

Price Target $115.93
Price Target Difference 39.94%
Analyst Consensus Buy
Analyst Count 15
Revenue Growth Forecast (5Y) 2.58%
EPS Growth Forecast (5Y) 8.86%
Stock Forecasts

Stock Splits

The last stock split was on February 17, 1999. It was a forward split with a ratio of 2:1.

Last Split Date Feb 17, 1999
Split Type Forward
Split Ratio 2:1

Scores

Merck & Co. has an Altman Z-Score of 4.7 and a Piotroski F-Score of 7.

Altman Z-Score 4.7
Piotroski F-Score 7